Best-in-class testing, with the most comprehensive results

Why We’re Different

Dedicated R&D

We have a dedicated research and development team of tick-borne disease experts who are relentlessly focused on and committed to developing the most precise and effective diagnostic tests for Lyme disease, Tick-Borne Relapsing Fever (TBRF) and other tick-borne diseases.


 
First to introduce Relapsing Fever Western Blot testing.
 First to introduce comprehensive Lyme ImmunoBlot and TBRF ImmunoBlot testing

More Comprehensive Testing

We test more relevant strains of Borrelia species and other associated tick-borne pathogens than other labs.

Superior Testing Criteria

We are hands-on and developed our in-house testing criteria for Lyme disease and other tick-borne diseases, based on decades of evidence and validation studies. Most labs use Lyme disease testing criteria that was developed in 1994, when much less was known about the disease and its pathogens.

Learn more >

Cutting Edge Technologies

We arm our talented scientists the most cutting edge technology available to enable them in finding new solutions that challenge the status quo of testing for Lyme and associated tick-borne diseases.

 

 First to introduce Relapsing Fever Western Blot testing.
 First to introduce comprehensive Lyme ImmunoBlot and TBRF ImmunoBlot testing

We are part of the Lyme Community

We are committed partners with other Lyme experts, Lyme groups and deeply dedicated to physician education.

Better Detection

IGeneX tests are based on the latest findings of Lyme disease and other tick-borne illnesses to provide the most complete and accurate results for diagnostic purposes.We test for more species than any other lab.

A Global Leader in Tick-borne Diseases

We are committed to unraveling the mysteries of Lyme disease and associated tick-borne diseases. Our scientists work directly with physicians, universities and other scientists that specialize in Lyme to continuously evolve our testing criteria and accelerate the development of new and increasingly more effective diagnostic methods.

Our Leadership

Dr. Jyotsna Shah

President & Laboratory Director
Dr. Jyotsna Shah is the President and Laboratory Director of IGeneX Clinical Laboratory, Palo Alto, CA. Dr. Jyotsna Shah is the President and Laboratory Director of IGeneX Clinical Laboratory, Palo Alto, CA. Dr. Shah has over 40 years of research experience in immunology, molecular biology and microbiology, has been published and holds more than 20 patents. After receiving her B.Sc. and M.Sc in Biological Sciences from UK and her Ph.D. in diagnostic immunology from Nairobi University in Kenya, Dr. Shah joined International Laboratory for Research on Animal Diseases (ILRAD) as a post-doctoral scientist and started the first DNA sequencing laboratory in E. Africa. On completion of her fellowship, she went on to join Harvard University’s Department of Tropical Medicine as a research fellow and continued work on development of molecular tools for diagnosis of parasitic diseases. Since then Dr. Shah has worked at several Biotechnology companies focusing on the development of novel molecular technologies for diagnosis of infectious diseases and has become a world expert on use of Fluorescent in Situ Hybridization (FISH) technique for direct detection of pathogens in clinical samples. Dr. Shah joined IGeneX as the Director of Research and Development in 1997 and in 2003 became Laboratory Director (clinical and research). During her time with IGenex she introduced the first Fluorescent In Situ Hybridization (FISH) test for Babesia and also set up the PCR department for tick-borne diseases. Under Dr. Shah’s direction, the laboratory has developed an excellent QA program and her scientific guidance, IGeneX has become the world’s leading reference laboratory for diagnosis of tick-borne diseases After receiving her B.Sc. and M.Sc in Biological Sciences from UK and her Ph.D. in diagnostic immunology from Nairobi University in Kenya, Dr. Shah joined International Laboratory for Research on Animal Diseases (ILRAD) as a post-doctoral scientist and started the first DNA sequencing laboratory in E. Africa. On completion of her fellowship, she went on to join Harvard University’s Department of Tropical Medicine as a research fellow and continued work on development of molecular tools for diagnosis of parasitic diseases.

Dr. Jyotsna Shah

President & Laboratory Director
Dr. Jyotsna Shah is the President and Laboratory Director of IGeneX Clinical Laboratory, Palo Alto, CA. Dr. Shah has over 40 years of research experience in immunology, molecular biology and microbiology, has been published and holds more than 20 patents. After receiving her B.Sc. and M.Sc in Biological Sciences from UK and her Ph.D. in diagnostic immunology from Nairobi University in Kenya, Dr. Shah joined International Laboratory for Research on Animal Diseases (ILRAD) as a post-doctoral scientist and started the first DNA sequencing laboratory in E. Africa.

Tom Paskert

VP of Finance
Tom Paskert has been the head of Finance for IGeneX since 2016. Prior to IGeneX, Tom worked at both large multi-national corporations as well as several smaller startups where he led funding efforts, which raised in excess of $250M. He has extensive experience growing organizations and installing infrastructures and has been involved with many mergers and acquisitions.
Tom Paskert has been the head of Finance for IGeneX since 2016. Prior to IGeneX, Tom worked at both large multi-national corporations as well as several smaller startups where he led funding efforts, which raised in excess of $250M.

Brenda Shiplett

Vice President of Administration
Brenda Shiplett has worked at IGeneX from its start in December 1991 and is the Vice President of Administration. Brenda worked with the former CEO at Allergenetics, Dr. Nick Harris, for years in the Clinical Studies and the Customer Service departments. After Allergenetics was purchased by 3M Corporation, she worked along side Dr. Harris in the Technical Services Department and as Marketing Communications Coordinator. When the Laboratory was sold by 3M Corporation, she assisted Dr. Harris in building IGeneX from the small laboratory of seven employees 25 years ago, to the exceptional laboratory that it is today.
Brenda Shiplett has worked at IGeneX from its start in December 1991 and is the Vice President of Administration. Brenda worked with the former CEO at Allergenetics, Dr. Nick Harris, for years in the Clinical Studies and the Customer Service departments.

Iris Cruz, MBBS, CLS

Clinical Laboratory Manager
Iris Cruz has an extensive background in operations, quality, and compliance. She joined IGeneX as a clinical scientist in 1992 and currently serves as the Clinical Laboratory Manager. Iris has a record of accomplishment installing and managing state-of-the art systems and quality control processes at IGeneX. She also provides significant leadership and coordination for the large numbers of clinical tests and validation studies performed by IGeneX.
Iris Cruz has an extensive background in operations, quality, and compliance. She joined IGeneX as a clinical scientist in 1992 and currently serves as the Clinical Laboratory Manager.

Robert Giguere

Director of Sales
Robert Giguere has been the Director of Sales at IGeneX since 1996. Robert has spent the majority of his career dealing with clinical laboratory medicine in the fields of genetics, endocrinology, and immunology. He did his undergraduate study at Providence College and then got his molecular biology training at MIT. He started his laboratory career at Nichols Institute in California and has held executive positions at a number of nationally recognized clinical laboratories. These include the molecular laboratory, Collaborative Research, and Repomedix in greater Boston. Prior to IGeneX, Robert was COO and Sr. VP at Boston BioMedical Clinical Laboratory.
Robert Giguere has been the Director of Sales at IGeneX since 1996. Robert has spent the majority of his career dealing with clinical laboratory medicine in the fields of genetics, endocrinology, and immunology.

Licensing & Accreditation

Click state to view license.

The IGeneX Advantage
The IGeneX Advantage
The IGeneX Advantage
The IGeneX Advantage
The IGeneX Advantage
The IGeneX Advantage